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Abstract 
Butyrate has been used extensively as a feed additive to improve gut health and to decrease Salmonella colonization 
in poultry. Salmonella mainly colonizes the ceca so butyrate concentrations should be increased in this gut segment. 
Discrepancies on the effects of butyrate on Salmonella colonization, described in the scientific literature, could thus 
be due to butyrate release location effects. In this study, newly developed butyrate formulations were evaluated 
for their effect on cecal butyrate concentrations and on colonization by Salmonella Enteritidis. In a first trial, broilers 
were randomly allocated to 7 dietary treatment groups with formulations based on different approaches to modify 
the butyrate release profile: release from wax matrices based on diffusion/erosion; micropellets supposedly release 
butyrate around pH 7 in the colon; tributyrin is based on the hydrolysis of esters in the small intestine. Fat-protected 
butyrate was included as a reference, because of its known effect on reduction of Salmonella colonization. Four days 
after infection, the number of cfu Salmonella per g cecal content and spleen were determined. Butyrate formulations 
in a wax matrix significantly reduced the Salmonella colonization in cecal content. In a second trial, wax and fat-pro-
tected butyrate treatments were replicated and results from the first trial were confirmed. Compared to the control 
group a higher proportion of butyrate concentration was observed in ceca for those groups with reduced Salmo-
nella colonization. This was associated with a beneficial shift in the cecal microbiota. In conclusion, formulations that 
increase cecal butyrate concentrations are superior in protecting against Salmonella Enteritidis colonization.
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is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the 
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mmons .org/licen ses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/publi cdoma in/
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Introduction
Despite years of strict monitoring and control in produc-
tion animals worldwide, Salmonella is still a major food-
derived zoonotic pathogen for humans. Poultry meat 
and eggs, as well as processed products thereof, still are 
the main sources of Salmonella infections in man [1, 2]. 
The most important Salmonella serotype associated with 
consumption of poultry products is Salmonella Enter-
itidis, which has been reported in more than half of the 
outbreaks in Europe in 2016 [1, 3]. This serotype causes 
egg-derived human infections, and is the consequence of 
systemic spread to the avian reproductive tract, resulting 
in internal egg contamination [4]. Poultry meat can be 
contaminated by a variety of serotypes, all colonizing the 
intestinal tract of broilers, such as serogroup C strains 
(e.g. Infantis), but also Typhimurium and Enteritidis. 
While in layers and breeders vaccination has been suc-
cessful in reducing Salmonella Enteritidis, one is still in 
need for an efficient strategy to reduce gut colonization 
levels in broilers.
Effects of short chain fatty acids (SCFA), especially 
butyrate, on gastrointestinal function of animals have 
been widely studied over the past years [5–8]. Guilloteau 
et al. give an overview of the favorable effects of butyrate 
on the gastrointestinal tract (GIT) of broilers, including 
stimulation of growth performance, anti-inflammatory 
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effects, maintenance of intestinal epithelial barrier 
integrity, and reduction of Salmonella colonization [9]. 
Butyrate has been extensively used as a feed additive to 
decrease Salmonella colonization in poultry in experi-
mental models and in the field. The results, however, 
are not always consistent. In addition to factors such as 
inclusion level, diet composition, age, and health status, 
release locations of butyrate may partly explain the incon-
sistent effects of butyrate on Salmonella colonization [6]. 
Decreased intestinal Salmonella colonization and shed-
ding was shown using in-feed coated butyric acid supple-
ments, but not using uncoated butyric acid supplements 
[7, 10, 11], pointing to formulation effects. Unprotected 
butyrate is readily absorbed in the upper GIT and will 
not reach the ceca [12]. The ceca are the preferred coloni-
zation site of Salmonella and thus butyrate formulations 
should preferably increase butyrate concentrations in this 
segment [5, 7, 9]. It is striking that no studies have been 
published yet to determine cecal butyrate concentra-
tions after application of in-feed butyrate supplements. 
Previous in  vitro research has shown distinctive release 
profiles of newly developed and commercially available 
butyrate formulations, produced using different encap-
sulation techniques [13]. A commonly used technique is 
embedding butyrate in vegetable fat matrices resulting in 
sustained release of butyrate in the broiler GIT [14]. One 
of the newly developed formulations for sustained release 
of drugs contains a food-grade petroleum-derived wax as 
embedding material [14]. This technique is used in the 
pharmaceutical industry and shows a sustained release 
of butyrate in vitro [13, 15]. Direct comparisons between 
these formulations with respect to their effects on Salmo-
nella colonization have not yet been performed.
Therefore, the purpose of the present study was to 
evaluate the effect of different butyrate formulations on 
Salmonella Enteritidis colonization and shedding, on the 
SCFA concentration in ceca, and on the cecal microbiota 
composition in broilers.
Materials and methods
Butyrate derivatives
Novel butyrate derivatives were developed using differ-
ent pharmaceutical technologies to produce formulations 
with different release patterns of butyric acid in the GIT 
of broilers. The first formulation consisted of a micro-
crystalline wax (Lunacera M wax beads, Füller GmbH, 
Lüneburg, Germany) and sodium butyrate (Adimix C, 
Nutri-Ad International NV, Dendermonde, Belgium), 
henceforth called Wax (resp. 70%/30% w/w). The second 
formulation included, in addition to the aforementioned 
components, S2004 soluble potato starch in dry pow-
der form (Sigma-Aldrich, Saint-Louis, USA), hereafter 
called Wax + (resp. 60%/30%/10% w/w). As described 
by Moquet [13], melt-extrusion and grinding were used 
to produce matrices of microcrystalline wax containing 
sodium butyrate. Prior to mixing, wax beads were ground 
at 15 000 rpm with a ZM-1000 grinder (Retsch, Haan, 
Germany) equipped with a 12-tooth rotor, and without 
screen. Each formulation was mixed with a pedal mixer 
model 305 (Dinissen, Sevenum, The Netherlands) at 
50% of the maximum speed for 5 min and subsequently 
extruded with a Baker–Perkins twin screw extruder. 
Extrusion settings were adjusted for each formulation 
in order to obtain homogenous, smooth-surfaced, non-
melted extrudates [12]. Extrudates were cooled down to 
room temperature overnight and subsequently ground at 
10 000 rpm with a ZM-1000 grinder (Retsch) equipped 
with a 12-tooth rotor without screen. Ground extrudates 
were sieved to obtain the 0.8-1.2 mm fraction (Figure 1).
A third novel butyrate formulation was developed by 
wet-extrusion, spheronization and fluidized-bed reactor 
coating, resulting in microencapsulated pellets contain-
ing butyrate with a pH-sensitive polymer, from now on 
called micropellets. Moquet [13] described the workflow 
of the production, which consisted of mixing microcrys-
talline cellulose (Avicel PH-101; 850 g/kg; FMC BioPoly-
mer, Philadelphia, USA) [16] and sodium butyrate (150 g/
kg; Admix C, Nutri-Ad International NV) (resp. 70%/30% 
w/w), and adding demineralized water in a drop-wise 
manner while mixing. The resulting wet mixture was 
extruded with a dome granulator model DG-L1 (Fuji-
Paudal, Osaka, Japan) and spheronized for 5 min (spher-
onizer model 15, Sturminster Newton, UK). The obtained 
pellets were dried overnight at room temperature and 
sieved afterwards to select the 0.8–1.2 mm fraction. 
A fluidized-bed reactor model GPCG1 (Glatt GmbH, 
Binzen, Germany) including a Wurster module was used 
to coat the pellets with  Eudragit® FS 30 D (Evonik Indus-
tries, Essen, Germany), a copolymer based on methyl 
acrylate, methyl methylacrylate and methacrylic acid that 
dissolves at pH higher than 7 (Figure 1).
In this study, these novel butyrate derivatives were 
tested in parallel with a commercially available fat-pro-
tected butyrate (Adimix Precision, Nutri-ad International 
NV), non-protected sodium butyrate (Adimix C, Nutri-
ad International NV), and tributyrin (T8626, Sigma-
Aldrich). The formulations were based on different 
approaches to modify butyrate release profile by either 
sustained release or targeted release. Sustained release 
refers to the prolonged release of an active compound 
over time based on enzymatic or mechanic erosion and 
diffusion mechanisms [13]. Release from wax matrices is 
based on diffusion/erosion and is nearly pH independent. 
As the active compound butyrate has been embedded in 
the matrix (wax), no distinction can be made between 
an inner and outer shell. Addition of starch to the wax 
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was used as a disintegrant, making the matrix less sus-
tainable compared to wax and influencing the release 
rate of butyrate [15]. Targeted release refers to localized 
delivery of the active compound based on organ-specific 
characteristics such as pH value or enzymatic activ-
ity [13]. For the micropellets a distinction can be made 
between an inner and outer shell, with the outer shell a 
pH sensitive polymer resistant against pH values lower 
than 7, and the inner shell containing the active com-
pound butyrate. As the pH increases throughout the GIT 
in broilers, the micropellets supposedly release butyrate 
around pH 7 in colon [17]. Endogenous lipases are able to 
cleave ester bonds of tributyrin at the first and third posi-
tion of the glycerol backbone [18]. As chickens have a low 
Figure 1 Workflow production process novel butyrate formulations [Right] Production process of wax by using hot melt extrusion, 
resulting in a wax matrix carrying the active pharmaceutical ingredient sodium butyrate. To obtain wax+ with the addition of starch, soluble 
potato starch in dry powder form was added during the mixing step. [Left] Production process of micropellets using wet-extrusion, spheronization 
and applying a pH-dependent coating. Final product is sodium butyrate with cellulose protected by an additional layer (purple sphere).
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pre-duodenal lipolytic activity, it is assumed that butyric 
acid will mostly be hydrolyzed in duodenum/jejunum by 
pancreatic lipases [19]. The fat-protected butyrate was 
included as a reference, because of its known effect on 
reduction of Salmonella colonization [7].
Bacterial strain
Salmonella enterica serotype Enteritidis phage type 4 
strain 147, a well characterized streptomycin resistant 
strain, was used in the experiments. This strain was origi-
nally isolated from egg white and has been shown to have 
a high capacity of colonizing the gut and internal organs 
in chickens [20]. The strain was grown for 6 h in Luria-
Bertoni medium (LB, Sigma, St. Louis, MO, USA), after 
which the number of CFU (colony-forming unit) per 
gram was determined by plating 10-fold dilutions of the 
bacterial suspension on xylose lysine deoxycholate agar 
(XLD, Oxoid, Basingstoke, UK). The bacterial suspension 
was stored at 4 °C during plate counting and was diluted 
in Phosphate-buffered saline (PBS) to obtain the desired 
infection dose.
Experimental design and diet
In a first experiment, 140-day-old male chicks were 
divided in 7 pens of 20 animals, assigned to 7 different 
dietary treatment groups. Included dietary treatments 
groups were given feed containing commercially available 
fat-protected butyrate, non-protected sodium butyrate, 
and the novel butyrate derivatives, i.e. wax, wax+, micro-
pellets or tributyrin. A control group receiving non-sup-
plemented feed was also included.
In the second experiment, only the dietary treatments 
which significantly reduced Salmonella colonization in 
cecum during the first trial were tested to confirm the 
effect on colonization. 120-day-old male chickens were 
divided in 6 pens of 20 animals, assigned to 3 different 
dietary treatment groups: non-supplemented feed, wax 
and commercially available fat-protected butyrate.
All feed additives were mixed in commercially available 
broiler feed (Versele-Laga, Deinze, Belgium) at a concen-
tration of 3 g/kg of sodium butyrate. The experiments 
were approved by the ethical committee of the Faculty of 
Veterinary Medicine, Ghent University (EC 2014/135 and 
EC2015/46).
Animals and experimental procedures
Day-old Ross-308 chicks were obtained from a local 
hatchery, and randomly divided in pens of 1.44  m2 with 
solid walls and a solid floor covered with fresh wood 
shavings. Optimal temperature for broilers was main-
tained during the trial, and a light schedule of 18 h light/6 
h darkness was applied. The birds had ad  libitum access 
to water and feed. At 17 days post-hatch all chicks were 
orally inoculated with  105 CFU of Salmonella Enteritidis 
per bird. Cloacal swabs of all animals were taken the day 
before infection and at day 1 and 3 post-infection (dpi). 
At 4 dpi all birds were euthanized, and samples from 
cecum and spleen were taken for bacteriological analysis. 
Additionally, intestinal content of cecum was collected 
for DNA extraction and 16S rRNA sequencing. Part of 
the cecal content was diluted 5 times in water, and after-
wards homogenized and centrifuged (2500 × g, 10 min) 
to obtain cecal water, for SCFA quantification.
Sample processing and analysis
Bacteriological analysis was performed as described by 
De Cort et  al. [21]. Cloacal swabs were plated directly 
on XLD plates supplemented with 100 μg/mL strepto-
mycin, and enriched in buffered peptone water (Oxoid, 
Basingstoke, UK) overnight at 37 °C. 1 mL of this sus-
pension was enriched by brilliant green tetrathionate 
broth (Merck, Darmstadt, Germany) after which plat-
ing was performed on XLD with streptomycin. Cecal 
samples and spleens were mechanically homogenized in 
buffered peptone water. Ten-fold dilutions were made in 
Hank’s Balanced Salt Solution (HBSS) and 6 droplets of 
20 µL of each dilution were plated on XLD plates supple-
mented with 100 μg/mL streptomycin. After incubation 
overnight at 37 °C, the number of colonies was deter-
mined and numbers of CFU/g organ calculated. Samples 
that were negative after direct plating were enriched in 
buffered peptone water and brilliant green tetrathionate 
broth overnight at 37 °C, followed by plating on XLD. 
When positive after enrichment these samples were pre-
sumed to have 83 CFU/g (detection limit of direct plat-
ing). Samples that were negative after enrichment were 
presumed to have 0 CFU/g.
SCFA quantification
Quantification of SCFA in cecal water was done by the 
method previously described by De Weirdt et al. [22]. In 
short, butyrate, propionate and acetate were extracted 
from the samples using diethylether. Extracts with methyl 
hexanoic acid 99% (Sigma-Aldrich) added as internal 
standard were analyzed on a gas chromatograph coupled 
with a flame-ionization detector and a split injector.
DNA extraction
For the extraction of DNA from the pellets obtained from 
the cecal contents the CTAB (cetyl trimethylammonium 
bromide) method described by Griffiths et  al. [23] and 
Kowalchuk et al. [24] was used. 100 mg of cecal content 
or 100 mg of the obtained pellets was homogenized with 
0.5 mL CTAB buffer (hexadecyltrimethylammonium bro-
mide > 98% (Sigma Aldrich) 5% (w/v), 0.35 M NaCl, 120 
nM K2HPO4) and 0.5 mL phenol–chloroform-isoamyl 
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alcohol (25:24:1) (Sigma Aldrich) in destruction tubes. 
After homogenization, the samples were shaken 6 times 
for 30 s using a beadbeater (MagnaLyser, Roche, Basel, 
Switzerland) at 6000 × g with 30 s in between shakings. 
The samples were centrifuged for 10 min at 8000 × g and 
300 µL of the supernatant was transferred to a new tube. 
Re-extraction was done with an additional 250 µL CTAB 
buffer. The samples were homogenized and centrifuged 
again for 10 min at 8000 × g and 300 µL of supernatant 
was added to the first 300 µL. Phenol was removed by 
adding an equal volume of chloroform-isoamyl alcohol 
(24:1) (Sigma-Aldrich). The aqueous phase was trans-
ferred to a new Eppendorf tube. Nucleic acids were 
precipitated with 2 volumes of PEG-6000 solution (poly-
ethyleenglycol 30% (w/v), 1.6 M NaCl). After 2 h at room 
temperature, a last centrifugation step was done for 20 
min at 13 000 g. The obtained pellet was rinsed with 1 mL 
of ice-cold, 70% (v/v) ethanol. After drying the pellet was 
resuspended in 100 µL RNAse free water (VWR, Leuven, 
Belgium).
16S rRNA amplicon sequencing and processing
The 16S rRNA sequencing was performed using MiSeq 
v2 technology (2 × 250 bp) from Illumina at the Geno-
Toul Genomics and Transcriptomics facility (Auzeville, 
France). This method has been described in detail by Ver-
meulen et al. [25].
Briefly, the hypervariable 16S rDNA V3–V4 region 
was targeted with PCR1F_460 (5′CTT TCC CTA CAC 
GAC GCT CTT CCG ATC TAC GGR AGG CAG CAG 3′) 
and PCR2R_460 (5′GGA GTT CAG ACG TGT GCT CTT 
CCG ATC TTA CCA GGG TAT CTA ATCCT3′) primers. 
After amplification and purification, single multiplexing 
was performed using a 6-bp index during a second PCR 
with 12 cycles. Those PCR products were again purified, 
and the quality and the fragment length were checked 
before being loaded onto an Illumina MiSeq cartridge 
according to the manufacturer’s instructions (Illumina 
Inc., San Diego, CA, USA). Next, sequences were demul-
tiplexed, trimmed, merged, filtered, and the resulting 
reads were clustered into Operational Taxonomic Units 
(OTUs) with an identity level of 97%. Chimera removal 
was done before the sequences of individual samples 
were mapped back to the representative OTUs and con-
verted to an OTU table. OTU tables of the 16S rRNA 
amplicon sequencing were analyzed using the QIIME 
software package (v1.9.0) [26]. Bacterial OTU sequences 
representative for taxonomy were aligned to the Silva 
v119 database 97% rep set. Rarefaction analysis was done 
using the “alpha_rarefaction.py” script and indicated that 
a sequencing depth of 10 000 reads was sufficient to ana-
lyze the bacterial community in the cecal samples from 
broilers.
Statistical analysis
Statistical analysis was carried out with InVivoStat (Cam-
bridge, UK), a statistical software package which uses 
R as its statistics engine [27]. Model assumptions were 
checked by visual inspection of the residuals. Differences 
of the mean between dietary treatment groups were ana-
lyzed with each pen as experimental unit. The differences 
were considered statistically significant at P ≤ 0.05.
Data of the bacteriological analysis and SCFA measure-
ments of the first trial did not meet model assumption of 
one-way ANOVA. Non-parametric Kruskal–Wallis test 
was used to analyze the data. All pairwise differences 
between the treatments were assessed using Behrens 
Fisher tests [28]. The data of the bacteriological analysis 
of the second trial and the SCFA measurements were 
assessed by one-way ANOVA using the following model: 
Yij = µ+ τi + εij , where  Yij represents the jth replicate (j 
is 1–6) for the ith treatment (i = control, wax or fat-pro-
tected butyrate). µ is the overall mean response, τi is the 
ith treatment effect, and εij is the random error associ-
ated with the jth replicate fed the ith treatment.
For data analysis of the 16S sequencing, the OTU tables 
were normalized by removing those OTUs with an abun-
dance lower than 0.01% in all samples. Multivariate anal-
ysis was done using the specific R package Vegan (version 
2.0–10) [29]. Dissimilarity matrices (based on the Bray–
Curtis dissimilarity index) were calculated from the OTU 
tables. Beta-diversity of the bacterial communities was 
studied by doing a Permutational multivariate analysis 
of variance (PERMANOVA) and a principal coordinate 
analysis (PCoA) on these dissimilarity indices.
To determine statistical differences in relative abun-
dances of the bacterial families, non-parametric Kruskal–
Wallis test was used to analyze the data (InVivoStat, 
Cambridge, UK).
Results
First trial: effects on Salmonella colonization
All cloacal swabs taken before infection were negative 
for Salmonella. One and 3 days post-infection 75% of the 
broilers in the control group had positive cloacal swabs. 
After 1 dpi 4 of the 6 dietary treatments with a butyrate 
derivative resulted in significantly lower numbers of 
animals shedding Salmonella, compared to the control 
group. Only the treatment tributyrin resulted in a signif-
icantly lower number of positive cloacal swabs at 3 dpi 
compared to the control group (Table 1).
Bacteriological analysis of cecum content after 4 dpi 
showed that the dietary treatment group fed with the 
butyrate derivative wax resulted in a significantly reduced 
cecal colonization by Salmonella Enteritidis compared 
to the control group (p = 0.0006), to the groups fed a 
diet with unprotected sodium butyrate (p = 0.0018) and 
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to the group fed micro encapsulated pellets (p = 0.0007) 
(Table 2). Figure 2 shows that the group fed a “wax” diet 
had a higher number of Salmonella negative ceca com-
pared to the other treatment groups. No differences were 
detected for Salmonella colonization of the spleen when 
comparing the mean log CFU/g (Table 2) but, in general, 
a higher number of Salmonella negative spleens were 
found in the groups supplemented with any butyrate con-
taining feed additive (Figure 3).
First trial: SCFA concentrations in ceca
A part of the collected cecal content at 4 dpi was used to 
quantify the amounts of acetate, propionate and butyrate 
present in ceca of the sacrificed birds. The sum of ace-
tate, propionate and butyrate concentrations in milli-
molar (mM) per litre (L) are referred to as total SCFA, 
and is used to calculate the relative amount of the differ-
ent SCFAs present in cecum. Table 3 gives an overview 
Table 1 Number of cloacal swabs positive for Salmonella Enteritidis strain 147 in the first trial 
Number of positive swabs on total per dietary treatment are given at 1 and 3 days post-infection (dpi) with  105 CFU Salmonella. Broilers were fed a diet either or not 
supplemented with a butyrate containing feed additive in a concentration of 3 g/kg of sodium butyrate.
* Significant difference in positive samples between control and dietary treatment with butyrate derivative (p-value < 0.05).
Dietary treatment
Control Fat-protected 
butyrate
Uncoated 
butyrate
Wax Wax+ Micropellets Tributyrin
1 dpi 15/20 6/19 9/20 2/19* 3/20* 4/20* 2/20*
3 dpi 15/20 6/19 11/20 6/19 7/20 9/20 2/20*
Table 2 Colonization of cecum and spleen by Salmonella Enteritidis strain 147 in the first trial 
Mean log CFU/g cecum and spleen values and standard deviation (SD) are shown at 4 dpi with  105 CFU Salmonella. Broilers were fed a diet either or not supplemented 
with a butyrate containing feed additive in a concentration of 3 g/kg of sodium butyrate.
Significant differences for cecum colonization among groups are indicated with different letters (a, b). No differences for spleen colonization was detected.
Dietary treatment
Control Fat-protected butyrate Uncoated butyrate Wax Wax+ Micropellets Tributyrin
Mean cecum (SD) 3.63a (1.27) 2.56ab (1.63) 3.45a (1.15) 1.56b (1.75) 2.87ab (2.25) 3.87a (1.76) 2.81ab (1.06)
Mean spleen (SD) 2.30 (0.79) 1.34 (1.08) 1.65 (0.87) 1.18 (1.05) 0.90 (1.03) 1.68 (1.10) 1.56 (1.13)
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Figure 2 Colonization of Salmonella in cecum of broilers in the 
first trial. Colonization of Salmonella in cecum of 21-day-old broilers 
fed a diet either or not supplemented with a butyrate containing feed 
additive in a concentration of 3 g/kg of sodium butyrate. Each dietary 
treatment consisted of 1 pen of 20 broilers, except for fat-protected 
butyrate and wax it was 1 pen of 19 each due to mortality before 
inoculation. The bar charts are showing the percentages of animals 
having a specific infection level of Salmonella as stated in the legend 
(specified log number of CFU per gram cecum content).
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Figure 3 Colonization of Salmonella in spleen of broilers in the 
first trial. Colonization of Salmonella in spleen of 21-day-old broilers 
fed a diet either or not supplemented with a butyrate containing feed 
additive in a concentration of 3 g/kg of sodium butyrate. Each dietary 
treatment consisted of 1 pen of 20 broilers, except for fat-protected 
butyrate and wax it was 1 pen of 19 each due to mortality before 
inoculation. The bar charts are showing the percentages of animals 
having a specific infection level of Salmonella as stated in the legend 
(specified log number of CFU per gram spleen).
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of those concentrations in mM and relative amounts 
of SCFA per treatment group, including differences 
between the treatment groups. In the text below only the 
differences with the control group are mentioned.
The absolute butyrate concentrations in mM/L didn’t 
show any differences between the treatment groups, 
but when comparing the relative amounts of butyrate 
(% butyrate/total SCFA) present in ceca, the group fed a 
wax diet and micropellets had a significantly higher per-
centage cecal butyrate as compared to the control group 
(resp. p < 0.0001 and p = 0.0043).
Comparing the relative amounts of acetate concen-
trations (%) showed that the wax group and the micro-
pellet group had a significantly lower percentage of 
acetate compared to the control group (resp. p < 0.0001 
and p = 0.0365).
The propionate concentrations (mM/L) were lower in 
the wax and micropellet group compared to the control 
group (resp. p = 0.0045, p = 0.0004). The relative amount 
of propionate present was only lower in micropellet 
group compared to the control group (p = 0.0034).
Second trial: effects on Salmonella colonization
In the second trial only the butyrate derivatives that 
reduced Salmonella colonization most significantly in 
the first trial were tested again (fat-protected butyrate 
and wax). All cloacal swabs taken before infection were 
negative for Salmonella, and no significant differences 
were detected in number of positive cloacal swabs after 1 
(p = 0.0626) and 3 dpi (p = 0.0513) (Table 4).
Bacteriological analysis of cecal content after 4 dpi 
showed that the dietary treatment group fed with wax 
had a significantly reduced cecal colonization by Sal-
monella Enteritidis compared to the control group 
(p < 0.0001) (Table 5). Figure 4 shows that the broilers fed 
a “wax” diet had a lower number of Salmonella positive 
ceca after direct plating compared to the other treatment 
groups. Bacterial counts in spleen revealed no differences 
in Salmonella colonization comparing the mean log 
CFU/g (Table 5), but in general a lower number of caeca 
were found to have Salmonella positive samples after 
Table 3 Concentrations of SCFAs measured in cecum of broilers in the first trial 
The broilers were fed a diet either or not supplemented with a butyrate containing feed additive in a concentration of 3 g/kg of sodium butyrate radical. Each dietary 
treatment consisted of 1 pen of 20 broilers. Measurements of SCFA concentrations were done at the age of 21 days after 4 days of Salmonella infection.
Significant differences for SCFA concentrations or percentages among dietary treatments are indicated with different letters per row (a, b, c, d, e).
Dietary treatment
Control Fat-protected 
butyrate
Uncoated butyrate Wax Wax+ Micro pellets Tributyrin
Butyrate (mM) (SD) 9.38a (3.58) 13.00a (3.01) 9.22a (4.69) 12.93a (7.45) 12.37a (3.09) 11.45a (3.90) 9.23a (4.67)
% butyrate/total SCFA 
(SD)
14.95ace (3.77) 17.93be (2.83) 14.81a (5.35) 25.15d (5.88) 18.26bc (2.22) 21.29bd (5.66) 16.41ab (6.00)
Acetate (mM) (SD) 51.52ab (18.48) 56.00a (9.02) 50.11ab (12.67) 38.60ab (23.44) 53.94ab (13.09) 41.92b (14.10) 42.38b (10.01)
% acetate/total SCFA 
(SD)
81.43b (13.29) 79.11bc (3.40) 81.18b (5.27) 72.18a (5.45) 79.26bc (2.66) 76.43ac (5.22) 78.55bc (5.46)
Propionate (mM) (SD) 2.28bd (0.99) 2.09ab (1.11) 2.54bd (0.97) 1.31ac (0.95) 1.65acd (0.76) 1.23c (0.68) 2.54b (0.97)
% propionate/total 
SCFA (SD)
4.17ac (1.93) 2.97bc (1.58) 4.01ac (2.23) 2.67acd (1.36) 2.47 cd (1.13) 2.28bd (0.99) 5.04a (2.54)
Total SCFA (SD) 63.18ab (21.01) 71.09b (11.15) 63.34ab (15.12) 52.84ab (29.62) 67.96ab (15.45) 54.6a (16.35) 54.15a (12.67)
Table 4 Number of cloacal swabs positive for Salmonella 
Enteritidis strain 147 in the second trial 
Number of positive swabs on total per dietary treatment are given at 1 and 
3 days post-infection (dpi) with  105 CFU Salmonella. Broilers were fed a diet 
either or not supplemented with a butyrate containing feed additive in a 
concentration of 3 g/kg of sodium butyrate.
Dietary treatment
Control Fat-protected 
butyrate
Wax
1 dpi 23/39 18/40 13/40
3 dpi 30/39 22/40 21/40
Table 5 Colonization of cecum and spleen by Salmonella 
Enteritidis strain 147 in the second trial 
Mean log CFU/g cecum and spleen values and standard deviation (SD) are 
shown at 4 dpi with  105 CFU Salmonella. Broilers were fed a diet either or not 
supplemented with a butyrate containing feed additive in a concentration of 3 
g/kg of sodium butyrate.
Significant differences for cecum colonization among groups are indicated with 
different letters (a, b). No differences for spleen colonization was detected.
Dietary treatment
Control Fat-protected butyrate Wax
Mean cecum (SD) 3.64a (1.47) 2.89ab (1.04) 2.40b (0.76)
Mean spleen (SD) 2.25 (0.64) 1.93 (0.08) 1.94 (0.12)
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direct plating in the groups supplemented with a butyrate 
containing feed additive (Figure 5).
Second trial: SCFA concentrations in cecum
Fat-protected butyrate yielded the highest total SCFA 
concentration of all tested groups, which was significantly 
higher compared to the wax treatment (p = 0.0008). 
Table  6 gives an overview of those concentrations in 
mM and relative amounts of SCFA per treatment group, 
including differences between the treatment groups.
Both absolute (mM) as well as relative (%) butyrate 
concentrations were significantly higher for both treat-
ment groups compared to the control group [control vs 
fat-protected butyrate (mM p = 0.0017, % p = 0.0096), 
control vs wax (mM and % p < 0.0001)]). The relative 
amount of butyrate was higher for the wax group com-
pared to the fat-protected butyrate group (p < 0.0001).
The wax treatment group had a higher butyrate con-
centration, but a significantly lower acetate and propion-
ate concentration compared to the control group, both in 
absolute and relative numbers (mM acetate p = 0.0013, % 
acetate p < 0.0001, mM propionate p = 0.0116; % propion-
ate p = 0.0008). Fat-protected butyrate yielded a higher 
concentration of acetate relative to the total SCFA and in 
mM compared to wax (p < 0.0001), and relatively higher 
percentage of acetate compared to the control group 
(p = 0.0037). Only in absolute numbers the propionate 
concentration was higher in the fat-protected butyrate 
group compared to the control group (p = 0.0058).
16S rDNA V3–V4 sequencing
Cecal content was collected from the 21-day-old chick-
ens in the first trial, 4 days after Salmonella infection, in 
groups receiving a standard diet supplemented with wax 
or fat-protected butyrate, or non-supplemented diet for 
21 consecutive days. DNA was extracted from the cecal 
content, and samples were sent for Illumina sequencing. 
Diversity or beta diversity of the cecal bacterial com-
munities of chickens in the control group and the group 
receiving wax and fat-protected butyrate are shown in a 
PCoA plot based on the Bray–Curtis dissimilarity index 
(Figure  6). The PCoA plot of the abundance based on 
Bray–Curtis dissimilarity matrix showed diet-related 
clustering (p < 0.001). Analyzing the alpha diversity, or 
richness, of the cecal content, expressed as the number 
of observed OTUs, revealed no significant differences 
between the dietary treatment groups (Figure 7).
Members of the phylum Proteobacteria were signifi-
cantly decreased in cecal contents from chickens that 
received the diet containing wax (0.6% p = 0.0004) or 
fat-protected butyrate (0.9% p = 0.0037) compared to 
the non-supplemented group (3.2%) (Figure 8). The same 
reduction was observed at family and genus level for resp. 
Enterobacteriaceae and Escherichia/Shigella (Table 7).
Figure  9 shows the relative abundances observed at 
family level. The most abundant family in analyzed 
samples was Lachnospiraceae, which was significantly 
increased in the wax group (62.5%) compared to the con-
trol group (52.8% p = 0.0181). A large proportion of this 
family was assigned to uncultured genera. Those OTUs 
together with the ones assigned to genus Blautia were 
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Figure 4 Colonization of Salmonella in ceca of broilers in the 
second trial. Colonization of Salmonella in ceca of 21-day-old broilers 
fed a diet either or not supplemented with a butyrate containing 
feed additive in a concentration of 3 g/kg of sodium butyrate. Each 
dietary treatment consisted of 2 pens of 20 broilers. The bar charts are 
showing the percentages of animals having a specific infection level 
of Salmonella as stated in the legend (specified log number of CFU 
per gram cecum content).
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Figure 5 Colonization of Salmonella in spleen of broilers in the 
second trial. Colonization of Salmonella in spleen of 21-day-old 
broilers fed a diet either or not supplemented with a butyrate 
containing feed additive in a concentration of 3 g/kg of sodium 
butyrate. Each dietary treatment consisted of 2 pens of 20 broilers. 
The bar charts are showing the percentages of animals having a 
specific infection level of Salmonella as stated in the legend (specified 
log number of CFU per gram spleen content).
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responsible for the shift to Lachnospiraceae in the wax 
group (Table 7).
Although no reduction of the abundance of the family 
Ruminococcaceae could be observed for the wax group 
compared to the control group (p = 0.0815), the genus 
Subdoligranulum within this family was significantly 
decreased in the wax group (0.3%) compared to the con-
trol group (4.6%, p = 0.0169) (Table 7).
The relative abundance of Lactobacillaceae was signifi-
cantly decreased for the wax group (3.8%) versus the con-
trol group (10.2% p = 0.0028), which was solely due to the 
reduction of the genus Lactobacillus.
Members of the family VadinBB60 were increased in 
abundance for the group receiving a diet containing wax 
(3.6%) compared to the control group (1.1% p = 0.0021).
Table 6 Concentrations of SCFAs measured in cecum of broilers in the second trial 
The broilers were fed a diet either or not supplemented with a butyrate containing feed additive in a concentration of 3 g/kg of sodium butyrate radical. Each dietary 
treatment consisted of 2 pens of 20 broilers. Measurements of SCFA concentrations were done at the age of 21 days after 4 days of Salmonella infection.
Significant differences for SCFA concentrations or percentages among dietary treatments are indicated with different letters per row (a, b).
Dietary treatment
Control Fat-protected butyrate Wax
Butyrate (mM) (SD) 8.48a (2.69) 12.45b (3.94) 13.45b (3.32)
% butyrate/total SCFA (SD) 15.02a (2.75) 18.39b (2.89) 27.16c (4.37)
Acetate (mM) (SD) 47.55a (14.12) 52.2a (9.74) 34.4b (7.65)
% acetate/total SCFA (SD) 82.70a (3.46) 78.71b (2.80) 69.09c (4.45)
Propionate (mM) (SD) 1.25a (0.51) 1.87b (0.69) 1.83b (0.56)
% propionate/total SCFA (SD) 2.29a (1.00) 2.89ab (1.20) 3.75b (1.28)
Total SCFA (SD) 57.29ab (16.4) 67.27a (13.23) 49.67b (9.80)
Figure 6 Diversity measures (beta-diversity) for the cecal bacterial communities in the second trial. Diversity measures (beta-diversity) 
for the cecal bacterial communities of chickens in the control group, and the groups receiving wax and fat-protected butyrate. Cecal content was 
collected from the 21-day-old chickens in the first trial, 4 days after Salmonella infection, while receiving a standard diet supplemented with wax 
(blue) or fat-protected butyrate (green) or non-supplemented (pink) for 21 consecutive days. The PCoA plot of the abundance based on Bray–
Curtis dissimilarity matrix showed diet-related clustering indicated with ellipses with p-value < 0.001, and was created with the web-based tool 
MicrobiomeAnalyst [47].
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Other significant differences were observed at family 
level with lower abundances for the families Defluviital-
eaceae and Peptoniphilaceae (Table 7).
Discussion
One of the challenges in the use of butyrate as feed 
additive is having a reliable system to deliver the mol-
ecule to the preferred location in the intestinal tract. 
Mainly two techniques can be found in the literature, 
being esters composed of butyric acid and glycerol, and 
butyrate embedded in a matrix of vegetable fat developed 
by spray cooling or film coating. The first is believed to 
yield higher butyrate concentrations in the upper GI tract 
while the latter would carry butyrate further down the 
GI tract, although data on effective butyrate concentra-
tions in the gut of poultry are scarce in the literature [30]. 
In the pharmaceutical field one of the strategies to bring 
active compounds past the gastric section in the GIT and 
induce a sustained release, is production of matrix pel-
lets by melt granulation based on microcrystalline waxes 
and starch derivatives. Drug release can be influenced by 
the processing parameters as well as the amount of starch 
due to change of matrix solubility [15]. Another strategy 
to bypass the stomach for orally administered pharma-
ceuticals, is the production of coated pellets by extrusion 
and spheronization and applying an enteric coating. The 
type of coating determines the drug release, and plays an 
important role in protecting drugs that are decomposable 
in the stomach by low pH or enzymatic degradation. A 
very site-specific release of the drug can be obtained with 
different types of coatings based on pH in the GIT, such 
as coated pellets for colon delivery with a coating soluble 
at pH 7 or higher [31].
Previous in vitro research showed that the matrix pel-
lets based on microcrystalline wax had a sustained release 
profile with an increased release of butyrate at the simu-
lated ileum. Commercially available fat-coated butyrate 
products with a different production process than the 
wax matrices (spray chilling vs hot melt extrusion) 
showed variations in release properties. Only two of the 
commercially tested products had an extended release 
profile in  vitro. In previous work, micropellets showed 
a targeted release profile. They were partially protected 
during gastric passage, followed by a rapid release in the 
enteric segments reaching pH 6.5 which was expected 
with the type of coating used [13]. We investigated the 
potential of newly developed butyrate derivatives and one 
commercially available fat-coated butyrate product with 
extended release profile to increase butyrate concentra-
tion in the ceca and to reduce colonization of Salmonella 
in the ceca. It was hypothesized that a more sustained 
release and an increase in cecal butyrate concentrations 
would decrease Salmonella colonization in the ceca. The 
butyrate effect on Salmonella is through suppression 
of invasion of Salmonella in epithelial cells and conse-
quently gut colonization [32]. One of the important tran-
scriptional activators of Salmonella pathogenicity island 
1 (SPI1) that regulates the invasion of Salmonella is the 
hilA gene [33]. Mutants in this gene have been shown to 
be poor gut colonizers [34]. Previously downregulation 
of hilA gene after exposure to butyrate and propionate 
was reported, while expression increased after expo-
sure of the bacteria to acetate [32, 35]. In our study we 
showed that in the ceca of chickens fed a wax matrix the 
relative proportion of butyrate increased, while acetate 
proportion was reduced compared to the control group. 
This shift in SCFA proportions indicates a less favorable 
environment for Salmonella to invade the epithelial cells 
of the cecal mucosa increasing the resilience of chickens 
against Salmonella infections. The results of increased 
SCFA concentrations in the hindgut are in line with the 
findings of Van den Borne [14], but in contrast with the 
research of Moquet et al. where no statistical differences 
could be observed in cecum and colon concentrations, 
but only numerical differences after feeding with the 
same fat-protected butyrate (although a large variation 
within the groups was reported) [13]. Although the birds 
were roughly the same age, the type of challenge may 
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Figure 7 Richness measures (alpha diversity) for the cecal 
bacterial communities in the second trial. The richness has 
been visualized for the control group and the group receiving 
wax and fat-protected butyrate. Cecal content was collected from 
the 21-day-old chickens in the first trial 4 days after Salmonella 
infection and receiving a standard diet supplemented with wax or 
fat-protected butyrate or non-supplemented diet for 21 consecutive 
days. The horizontal lines at the bottom, the middle and the top 
of the box represent the first quartile, median and third quartile, 
respectively. The whiskers indicate the min/max value.
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play a role in these discrepancies, namely bacterial chal-
lenge by Salmonella infection versus a dietary challenge 
induced by rapeseed meal diet.
Literature indicates that supplementing diets of broil-
ers with butyrate influences cecal microbiota composi-
tion in a way that is beneficial for the health and growth 
performance when the microbiota is disturbed by for 
example an enteric disease or nutritional challenge [36–
38]. We also observed that supplementing butyrate in 
a wax-based carrier can reduce the Salmonella count, 
which very likely explains the observed decrease of Enter-
obacteriaceae. We observed that wax coated butyrate 
Figure 8 Relative abundance of the most important bacterial phyla. Visualization of the relative abundance of the most important bacterial 
phyla present in the dietary treatment groups. Cecal content was collected from the 21-day-old chickens in the first trial 4 days after Salmonella 
infection and receiving a standard diet supplemented with wax or fat-protected butyrate or non-supplemented for 21 consecutive days. DNA was 
extracted from the cecal content, and relative abundances are shown as determined by Illumina sequencing, and visualized with the web-based 
tool MicrobiomeAnalyst [47].
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increased the relative abundance of Lachnospiraceae, a 
family containing important butyrate-producing bac-
teria. Besides an increase of genera within this family 
that are not yet cultured, members of the genus Blautia 
were also increased with wax supplementation. Species 
belonging to Blautia can use carbohydrates as a substrate 
to produce lactate and acetate as the major end product 
of glucose fermentation [39, 40]. They are associated with 
a reduction of incidence of inflammatory bowel disease 
in humans [41]. Another family with important butyrate-
producers is Ruminococcaceae. Subdoligranulum, one of 
the genera in this family that has butyric and lactic acid 
as major end products of fermentation, was decreased in 
abundance after wax supplementation in this study [42]. 
Analyzing the sum of both families resulted in no differ-
ences between the dietary treatment groups. Accordingly, 
it is not clear whether the observed increased concentra-
tions in cecal butyrate in the supplemented groups are 
mainly due to the exogenous butyrate or whether endog-
enous butyrate is also adding on top of this.
In our study a significant decrease of cecal Lactobacil-
laceae was observed when butyrate was added to the 
diet in a wax or fat-coated form. Lactobacillus spp. are 
probably the most commonly used probiotics and they 
are linked to several benefits for intestinal health [43]. 
Several other studies with butyrate supplementation 
reported the same observation regarding Lactobacillus 
reductions, both in broilers in cecal lumen as well as in 
weaned piglets in ileal and colonic lumen [44, 45]. Based 
on a previous study by De Boever et al. showing that Lac-
tobacillus reuteri plays an active role in microbial bile salt 
hydrolase production resulting in impaired lipid absorp-
tion and therefore dietary energy losses, it is hypothe-
sized that a reduction of Lactobacillaceae can play a role 
in reduced energy loss, and thus increases nutrient uti-
lization with a better feed conversion ratio as profitable 
result [46]. In a recent study in pigs, a better feed effi-
ciency was correlated amongst others with an increase of 
Clostridiales genus VadinBB60 [46]. In our study a higher 
abundance of VadinBB60 was observed with wax dietary 
treatment, but feed conversion ratio was not evaluated.
Table 7 Relative abundances of bacterial phyla, families and genera in the microbial community in ceca of broilers 
At the age of 21 days after 4 days of Salmonella infection relative abundances in cecal content were determined with 16S rRNA V3–V4 amplicon sequencing. The 
broilers were fed a diet either or not supplemented with a butyrate containing feed additive in a concentration of 3 g/kg of sodium butyrate. Each dietary treatment 
consisted of 2 pens of 20 broilers.
Significant differences for relative abundances of bacterial phyla, families and genera among dietary treatments are indicated with different letters per row (a, b).
Phylum Family Genus Dietary treatment
Control Wax Fat-protected 
butyrate
Mean SD Mean SD Mean SD
Firmicutes 91.63a 6.10 93.94a 2.92 94.57a 2.73
Lachnospiraceae 52.75a 12.17 62.48b 6.13 50.68a 11.56
Blautia 12.12a 4.26 16.44b 4.87 12.96ab 4.51
Other/uncultured 29.80a 10.22 37.83b 7.05 29.72ab 11.06
Ruminococcaceae 18.38ab 9.15 13.85a 4.85 24.15b 9.19
Subdoligranulum 4.56a 7.44 0.31b 0.41 5.85ab 10.65
Anaerotruncus 2.55a 1.66 2.23a 1.51 2.98a 1.65
Other/uncultured 11.03a 4.18 11.19a 4.04 14.69a 5.16
Lactobacillaceae 10.22a 8.19 3.82b 3.86 7.54ab 6.14
Lactobacillus 10.22a 8.19 3.82b 3.86 7.54ab 6.14
Streptococcaceae 7.91a 4.54 8.34a 4.95 7.96a 3.00
VadinBB60 1.14a 1.02 3.62b 2.33 2.44ab 2.77
Defluviitaleaceae 0.15a 0.05 0.30b 0.16 0.03b 0.14
Peptoniphilaceae 0.05a 0.04 0.01b 0.02 0.00b 0.01
Lachnospiraceae + Ruminococcaceae 71.13a 8.11 76.33a 6.84 74.84a 7.19
Proteobacteria 3.16a 5.28 0.56b 0.45 0.91b 1.32
Enterobacteriaceae 1.80a 1.21 0.54b 0.44 0.29b 1.32
Escherichia/Shigella 1.76a 1.17 0.54b 0.44 0.88b 1.33
Actinobacteria 91.64a 6.10 93.94a 2.92 94.58a 2.73
Other 4.69a 3.58 5.03a 2.87 4.11a 2.20
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In conclusion, the newly developed microcrystal-
line wax matrix as carrier for sodium butyrate may be a 
suitable feed supplement to protect broilers against Sal-
monella Enteritidis. In this study the matrix was tested 
against a single strain Salmonella Enteritidis 147 Strep, 
which is known to colonize the gut and internal organs of 
chickens to a high level. Compared to other carriers, the 
delayed release of butyrate induced a higher relative cecal 
butyrate concentration and a decrease of Salmonella col-
onization in ceca. The dietary treatment of wax contain-
ing sodium butyrate modulated the cecal microbiota of 
the challenged chickens.
Figure 9 Relative abundance of the most abundant bacterial families. Visualization of the relative abundance of the most abundant bacterial 
families present in the caeca of animals in the different dietary treatment groups. Cecal content was collected from the 21-day-old chickens in the 
first trial 4 days after Salmonella infection and receiving a standard diet supplemented with wax or fat-protected butyrate or non-supplemented for 
21 consecutive days. DNA was extracted from the cecal content, and relative abundances are shown as determined by Illumina sequencing, and 
visualized with the web-based tool MicrobiomeAnalyst [47].
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